USFDA concludes inspection at Hikals Bangalore facility
USFDA concludes inspection at Hikals Bangalore facility

USFDA concludes inspection at Hikals Bangalore facility

DSIJ Intelligence Article rating: 5.0

Hikal Limited announced having received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) unit located in Bangalore.

BHEL receives Rs. 200 crore order
BHEL receives Rs. 200 crore order

BHEL receives Rs. 200 crore order

DSIJ Intelligence Article rating: 5.0

Bharat Heavy Electricals Ltd (BHEL) won an order for renovation, modernisation and uprating (RM&U) of the Chilla Hydro Electric Plant (HEP) from Uttarakhand Jal Vidyut Nigam Ltd (UJVNL). The project is valued at over Rs. 200 crore.

Bank Nifty: 30600 to 30800 level likely to act as crucial resistance
Bank Nifty: 30600 to 30800 level likely to act as crucial resistance

Bank Nifty: 30600 to 30800 level likely to act as crucial resistance

Vinayak Gangule Article rating: 4.8

On the downside, the immediate supports are seen around 29890-29630 levels as it is the confluence of 8-day EMA and 13-day EMA. On the upside, the Bank Nifty needs to sustain above the zone of 30800-30600 level to maintain its positive stance. If it is unable to surpass this level, then there are chances of the index entering a corrective to sideways phase.

Sensex closes at record high
Sensex closes at record high

Sensex closes at record high

Nidhi Jani Article rating: 5.0

 Traders were encouraged with Prime Minister Narendra Modi’s statement that India is among the top 10 destinations for foreign direct investment (FDI) in the world and received $286 billion of FDI in the last five years.

How equity MFs performed in last one year?
How equity MFs performed in last one year?

How equity MFs performed in last one year?

DSIJ Intelligence Article rating: 3.0

There have been quite some noteworthy events bearing significant influence on the stock markets in the past one year, right from credit events to the slashing of corporate tax rates. Let's figure out the performance of equity MFs in the past one year amidst all the buzz?

Prakash Industries gains 4 per cent on mining operations commencement
Prakash Industries gains 4 per cent on mining operations commencement

Prakash Industries gains 4 per cent on mining operations commencement

Nidhi Jani Article rating: 3.7

We expect the company's operating margin to improve going forward as the recent extraction of iron ore is expected to bring down costs since iron ore is a major raw material in the steel producing process.

Strides Pharma jumps post receiving USFDA nod for Ranitidine
Strides Pharma jumps post receiving USFDA nod for Ranitidine

Strides Pharma jumps post receiving USFDA nod for Ranitidine

DSIJ Intelligence Article rating: 2.3

On November 1, 2019, the USFDA issued an update containing the latest information of Ranitidine. Concluding from the results provided by the USFDA, Strides Pharma’s Ranitidine Tablets 300 mg (Rx) are within acceptable limits for NDMA of 96 nanograms per day or 0.32 ppm.

Inox Wind gains on order
Inox Wind gains on order

Inox Wind gains on order

DSIJ Intelligence Article rating: 3.7

Inox Wind has received an order from ReNew Power Ltd under the SECI - 2 regime for 38MW wind power project to be developed at Anjar in Gujarat. Reacting to this news, the stock of the company gained by 4.19 per cent in today's morning trading session.

RSS
First30873088308930903092309430953096Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR